Close
Find your Coloplast country website

Key figures

Download the key figures in Excel

DKK million 2014/15 2013/14
2012/13
2011/12
2010/11
           
Income statement          
Revenue 13,909 12,428
11,635
11,023
10,172
Research and development costs -442 -390
-380
-342
-415
Operating profit before interest, tax, depreciation and amortisation 2,020 3,573
4,160
3,756
3,108
Operating profit before special items 4,535 4,147
3,672
3,255
2,581

Special items1)

3,000 1,000 0 0 0
Operating profit (EBIT) 1,535 3,147
3,672
3,255
2,581
Net financial income and expenses -289 46
-46
-300
-124
Profit before tax 1,245 3,191
3,625
2,954
2,456
Net profit for the year 899 2,390
2,711
2,194
1,819
           
Revenue growth          
Annual growth in revenue, % 12 7
6
8
7
Growth breakdown:          
Organic growth, % 7 9
7
6
6
Currency effect, % 5 -2
-1
2
1
           
Balance sheet          
Total assets 10,817 10,379
9,564
10,176
9,218
Invested capital 4,702 6,088
6,320
6,295
6,312
Equity at year end 4,706 6,283
6,769
6,042
4,478
           
Cash flows and investments          
Cash flows from operating activities 3,337 3,149
3,136
2,649
2,205
Cash flows from investing activities -468 -777
-159
-390
-954
Investment in property, plant and equipment, gross -583 -505
-409
-317
-230
Free cash flow 2,869 2,372
2,977
2,259
1,251
Cash flows from financing activities -2,963 -2,898
-3,430
-1,653
-1,461
           
Key ratios          
Average number of employees, FTEs 9,303 8,741
8,143
7,624
7,328
Operating margin, EBIT, % 11 25
32
30
25
Operating margin, EBIT, before special items, % 33 33 32 30 25
Operating margin, EBITDA, % 15 29
36
34
31
Return on average invested capital before tax (ROIC), %2) 62 60
58
52
41

Return on average invested capital after tax (ROIC), %2)


48 49
44
38
30
Return on equity, % 16 37
42
42
46
Equity ratio, % 44 61
71
59
49
Net asset value per outstanding share, DKK4) 22 30 32
29
21
           
Per share data          
Share price, DKK4) 473 494
314
242
161
Share price/net asset value per share4) 22 17
10
9
8
Average number of outstanding shares, millions4) 211 211
211
210
210
PE, price/earnings ratio 111 44
24
23
19
Dividend per share, DKK3) 4) 12.5 11.5
10.0
4.0
2.8
Pay-out ratio, %5) 82 77 78
38
32
Earnings per share (EPS), diluted4) 4 11
13
10
9
Free cash flow per share4) 14 11
13
11
9
           
1) Special items cover potential settlements and costs in connection with the law suits alleging injury resulting from the use of transvaginal surgical mesh products
2) For the 2014/15 and 2013/14 financial years, this item is before Special items. After Special items, ROIC before tax is 28%/51%, and ROIC after tax is 21%/38%.
3) The figure shown for the 2014/15 financial year is the proposed dividend.           

4) The 2012/13 figure has been restated to reflect a 1-to-5 split of the company's A and B shares in the 2012/13 financial year. 

 

5) For the 2014/15 and 2013/14 financial years, this item is before Special items. After Special items, the pay-out ratio is 294%/101%

 
The key ratios have been calculated and applied in accordance with “Recommendations & Financial Ratios 2015” issued by the Danish Society of Financial Analysts.
View desktop version